Free shipping on all orders over $ 500

Selexipag

Cat. No. M14045

All AbMole products are for research use only, cannot be used for human consumption.

Selexipag Structure
Synonym:

NS-304; ACT-293987

Size Price Availability Quantity
5mg USD 70  USD70 In stock
10mg USD 110  USD110 In stock
50mg USD 260  USD260 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Selexipag (NS-304) is the methanesulfonamide precursor compound of ACT-333679 and an orally effective prostacyclin (PGI2) receptor agonist. It can be used in studies related to pulmonary arterial hypertension.

Chemical Information
Molecular Weight 496.62
CAS Number 475086-01-2
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] No authors listed. Selexipag for pulmonary arterial hypertension

[2] Lon Genecand, et al. Selexipag for the treatment of pulmonary arterial hypertension

[3] Evangelia Panagiotidou, et al. An evaluation of selexipag for the treatment of pulmonary hypertension

[4] No authors listed. Selexipag

[5] Olivier Sitbon, et al. Selexipag for the Treatment of Pulmonary Arterial Hypertension

Related Prostaglandin Receptor Products
Prostaglandin D2

Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals. PGD2 plays a protective role by suppressing inflammation.

Tafluprost acid

Tafluprost acid (AFP-172) is a selective prostanoid FP receptor agonist. Tafluprost acid shows a high affinity for human prostanoid FP receptor with Ki and EC50 values of 0.4 nM and 0.53 nM, respectively. Tafluprost acid has 126 times weaker binding affinity for prostanoid EP3 receptor (IC50=67 nM) than for the prostanoid FP receptor.

TG8-260 

TG8-260 is a second-generation EP2 antagonist developed to alleviate the pathology of central nervous system and peripheral diseases driven by inflammation.

Camonagrel 

Camonagrel is a compound that has inhibitory effects on Prostaglandin E2.

BAY 73-1449 

BAY 73-1449 is a selective antagonist of prostacyclin receptor (IP), with high potency (IC50 of less than 0.1 nM) in cAMP assays in Human HEL cells and rat DRG.

  Catalog
Abmole Inhibitor Catalog




Keywords: Selexipag, NS-304; ACT-293987 supplier, Prostaglandin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.